Real-life experience of Omalizumab in adult Cystic Fibrosis patients with allergic severe asthma and Allergic Bronchopulmonary Aspergillosis

M. Bellocchia (Orbassano, Italy), G. Bonizzoni (Orbassano, Italy), C. Biglia (Orbassano, Italy), C. Bena (Orbassano, Italy), E. Clivati (Orbassano, Italy), V. Difino (Orbassano, Italy), F. Traversa (Orbassano, Italy), S. Demichelis (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy), C. Albera (Orbassano, Italy), B. Messore (Orbassano, Italy)

Source: International Congress 2018 – Cystic fibrosis in adults: current research
Session: Cystic fibrosis in adults: current research
Session type: Thematic Poster
Number: 1323
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bellocchia (Orbassano, Italy), G. Bonizzoni (Orbassano, Italy), C. Biglia (Orbassano, Italy), C. Bena (Orbassano, Italy), E. Clivati (Orbassano, Italy), V. Difino (Orbassano, Italy), F. Traversa (Orbassano, Italy), S. Demichelis (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy), C. Albera (Orbassano, Italy), B. Messore (Orbassano, Italy). Real-life experience of Omalizumab in adult Cystic Fibrosis patients with allergic severe asthma and Allergic Bronchopulmonary Aspergillosis. 1323

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Burden of Allergic Bronchopulmonary Aspergillosis (ABPA) in the India bronchiectasis registry.
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019


Allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Eur Respir J 2001; 17: 156
Year: 2001


Allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Eur Respir J 2001; 17: 1052-1053
Year: 2001


Allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Annual Congress 2009 - Update on eosinophilic lung diseases
Year: 2009


Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis
Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020
Year: 2020



Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


The efficacity of omaluzimab in a case series with allergic bronchopulmonary aspergillosis and cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015


Vitamin D level in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and aspergillus sensitization
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with cystic fibrosis (CF)
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010

Allergic bronchopulmonary aspergillosis as aetiology of bronchiectasis: data from the German bronchiectasis registry PROGNOSIS
Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Year: 2020


Living with allergic bronchopulmonary aspergillosis
Source: Breathe, 15 (2) 108; 10.1183/20734735.0170-2019
Year: 2019



Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014



Allergic rhinitis: management of patients
Source: Eur Respir J 2006; 28: Suppl. 50, 691s
Year: 2006

Allergic bronchopulmonary mycosis due to rhizopus nigricans in two siblings with and without CF?
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016


Airway remodelling easily develops in patients with allergic bronchopulmonary aspergillosis
Source: Annual Congress 2009 - Airways remodelling
Year: 2009



Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


Prognosis of allergic and non-allergic asthma
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016

Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?
Source: Eur Respir Rev 2010 19: 261-263
Year: 2010